Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression
Authors:
- Nasim DanaNDNasim Dana
- Maryam NasirianMNMaryam Nasirian
- Golnaz VaseghiGVGolnaz Vaseghi
- Kiyan Heshmat-GhahdarijaniKHKiyan Heshmat-Ghahdarijani
- Behrooz AtaeiBABehrooz Ataei
- Azam MosayebiAMAzam Mosayebi
- Amirreza ManteghinejadAMAmirreza Manteghinejad
- Shaghayegh Haghjooy JavanmardSJShaghayegh Haghjooy Javanmard
Open Access
- 1 January 2022
- journal article
- research article
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 54 (3) , 206-212
Abstract
Objective: There is no conclusive evidence to suggest vitamin D level can prevent or treat infection with the new coronavirus disease 2019. This study aimed to investigate the effects of serum level of vitamin D in patients with coronavirus disease 2019 on death, severity, and hospitalization duration. Materials and Methods: Baseline characteristic of patients was extracted from the Isfahan coronavirus disease 2019 registry database (I-CORE). Blood samples were taken from all patients to measure the level of vitamin D (25-hydroxyvitamin D) and categorized. The effect of 25(OH) D on death, severity, and hospitalization duration was analyzed by logistic regression. Results: Among our study patients, 5.5% had a severe deficiency of vitamin D, 23.7% deficiency, and 24.8% insufficiency. Of the 107 patients who died, 7.5% were severely deficient in vitamin D. We found that vitamin D deficiency had no significant effect on death, disease severity, and hospitalization (P > .05). However, having at least one comorbidity increased the odds of death five times after adjusting age > 60 years and gender (P < .0001). The results showed that among all comorbidities, diabetes has the greatest impact on the outcomes as it raised the odds of death, disease severity, and length of hospital stay by 2.23,1.72, and 1.48, respectively, after controlling the age > 60 and gender (P = .0002, P=.08, P=.012). Conclusions: The mortality, disease severity, and hospitalization of coronavirus disease 2019 patients seem to be not affected by the low levels of 25(OH)D. However, the synergy between vitamin D levels and comorbidities, age, and gender could affect the outcome of coronavirus disease 2019 patients. Cite this article as: Dana N, Nasirian M, Vaseghi G, et al. Vitamin D level in laboratory confirmed COVID-19 and disease progression. Eurasian J Med., 2022;54(3):206-212.Keywords
This publication has 24 references indexed in Scilit:
- Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19Journal of Medical Virology, 2020
- Prevalence of vitamin D deficiency in Iran: A systematic review and meta-analysisNutrition and Health, 2018
- Updates on the Status of Vitamin D as a Risk Factor for Respiratory Distress SyndromeAdvances in Pharmacological Sciences, 2018
- Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin systemMolecular Medicine Reports, 2017
- Vitamin D Status, Gender Differences, and Cardiometabolic Health DisparitiesAnnals of Nutrition and Metabolism, 2017
- Modulation of the Immune Response to Respiratory Viruses by Vitamin DNutrients, 2015
- Estrogen Receptor α Signaling in T Lymphocytes Is Required for Estradiol-Mediated Inhibition of Th1 and Th17 Cell Differentiation and Protection against Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2011
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011
- A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiencyMolecular Nutrition & Food Research, 2010
- 1α,25-Dihydroxy-3-epi-vitamin D3, a natural metabolite of 1α,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cellsMolecular Genetics and Metabolism, 2002